Aspergillus fumigatus is an important fungal pathogen of the immunocompromised host that causes a life-threatening respiratory infection, invasive pulmonary aspergillosis (IPA) (2) . The disease is acquired by the inhalation of airborne conidia. Following germination, hyphae invade through the walls of bronchi and smaller airways into the lung parenchyma, resulting in a necrotizing bronchopneumonia. The fungus can spread to invade the arterial tree, causing vascular occlusion with hemorrhagic infarction and dissemination to other organs. As the infection progresses, necrosis of the pulmonary parenchyma may lead to cavitation.
Little is known about the virulence determinants of A.
fiumigatus, though it has been suggested that the production of extracellular proteases, such as elastase(s), by the fungus may be important in allowing it to invade and grow in lung tissue. There is indirect evidence to support this hypothesis. Rhodes et al. (20) showed that while only 13 of 27 isolates of Aspergillus spp. recovered from the environment were elastase producers, all 11 clinical isolates produced the enzyme. In a study by Kothary et al. (11) , environmental isolates of A. fumigatus were assessed for their ability to produce elastase both by a plate assay and in liquid culture. Isolates which produced elastase caused higher mortality and tissue invasion than elastase nonproducers when tested in a murine model of IPA. Those authors proposed that fungal elastase might be important in the process of tissue invasion by A. fumigatus. However, the strains tested in their study were not isogenic, and therefore, the correlation between elastase production and pathogenicity may have been due to other factors associated with the elastase-producing strains. Also, it is noteworthy that the same group of workers has since * Corresponding author.
reported that isolates designated "elastase nonproducers" in their original study were in fact elastase producers when assayed by a different method (8) . Furthermore, in sections of lung tissue from patients with IPA, Denning et al. (6) found no evidence of elastinolysis in the walls of arteries which had been invaded by the fungus. The biochemical basis of extracellular elastinolysis by A. fumigatus has been investigated by several groups (8, 17, 19) , who have all identified an alkaline protease with elastinolytic activity and a molecular mass (Mr) of 32 to 33 kDa. Reichard et al. (19) characterized an alkaline protease, AFAlp, as having an estimated Mr of 32 kDa and a pl of 7.9. The sequence of amino acids at the N terminus of the mature protein indicated that it is closely related to an alkaline protease of Aspergillus oryzae (25) that is a member of the subtilisin family. Monod et al. (17) purified from A. fumigatus an alkaline protease with an Mr of 33 kDa; subsequent identification and sequencing of both genomic and cDNA clones encoding this protease (10) showed that it is identical to AFAlp. More recently, Frosco et al. (8) reported an alkaline protease with an Mr of 32 kDa and a pl of 8.8. They concluded that this was not AFAlp because of discrepancies in the isoelectric point and inhibitor profile of their enzyme; however, they used a different substrate to assay the residual activity of their enzyme after the addition of inhibitors.
We used gene disruption to inactivate the AFAlp gene in an elastase-producing clinical isolate of A. fumigatus. The mutant is deficient in extracellular elastinolytic and proteolytic activities over the pH range 6 to 10.4 and lacks an extracellular protein of 33 kDa (24) . This work showed that in this isolate at least, there is only one alkaline protease with elastinolytic activity. In this study, we have compared the pathogenicity of isogenic wild-type and AFAlp disruptant strains ofA. fumigatus in two murine models of IPA and were unable to show a difference between them in terms of disease phenotype. (24) . Strain 234e was derived from strain 234 by single-copy ectopic integration of the disruption vector pID21, which contains the hygromycin phosphotransferase gene of Eschenichia coli under the control of the trpC promoter of Aspergillus nidulans (4 ouraud dextrose agar (150 ml) at the base of the inhalation chamber was inoculated either with 3 x 107 conidia in 1 ml of saline or with saline alone and incubated at 37°C for 3 days. White male mice (strain CD1; Charles River Breeders, Kent, United Kingdom) weighing 14 to 17 g were immunosuppressed with cortisone acetate (Sigma, Poole, United Kingdom) (2 mg in 0.2 ml of 0.1% Tween 80) given subcutaneously on days -2 and 0. The animals were kept in cages with filter tops and given sterile food and sterile bedding.
MATERIALS AND METHODS
Tetracycline (0.5 mg/ml; Sigma) was added to the drinking water. On day 0, mice were introduced into the side arms of the chambers, and the conidia were dispersed by pumping 100 ml of air over the fungal colony at the base of the flask. isolates recovered from the lungs of mice inoculated with 237d were all elastase nonproducers by the elastin plate assay. Histological examination of lung tissue failed to show any differences between mice inoculated with strains 237 and 237d. Representative sections are shown in Fig. 4 . Infection was widely distributed throughout the lung fields, involving many alveolar spaces. Although widespread, the individual colonies were small. A polymorphonuclear (PMN) leukocyte infiltrate was present around the colonies. Limited elastin degradation was observed in the pneumonic foci caused by infection with both the wild-type and AFAlp disruptant strains.
(ii) Intranasal model. Since animals were immunosuppressed for a longer period in the intranasal-inoculation model, it was necessary to add antibiotics to the drinking water and provide animals with sterile bedding and food. This ensured that mice given only corticosteroids remained healthy. Animals that were inoculated with strain 234 in the absence of immunosuppression showed no effect from exposure to conidia. The lowest level of inoculum of strain 234
given to immunosuppressed mice which gave reproducible survival curves was 8 x 105 conidia; only 30 to 50% of mice receiving 4 x 105 conidia developed respiratory illness (data not shown). There was no significant difference in the survival of mice inoculated with each of the fungal strains when experiments were analyzed both individually and together (Fig. 3 ). An attempt was made to assess the fungal load in mice by measuring CFU per gram of lung from infected animals, but there was wide variation in the counts from animals inoculated with the same strain which developed IPA at the same time after inoculation. In agreement with previous work on A. fumigatus (22) , we conclude that measuring CFU is not a reliable indicator of fungal load in lung tissue.
No differences were observed in the histology for animals inoculated by the intranasal route with strain 234 or 234d (Fig. 4) . Discrete fungal colonies were seen in large airways, filling the lumen, invading through the wall, and in some cases invading the adjacent branch of the pulmonary artery. The colonies were surrounded by a dense PMN leukocyte infiltrate in which a large number of cells appeared degenerate. Focal breakdown of elastin was seen in some bronchial and vessel walls at the site of fungal invasion (Fig. 4) . Adjacent sections that were stained with hematoxylin and eosin showed that PMN leukocytes were often present at the sites of elastin breakdown.
To investigate the possibility that integration of the disruption vector results in an alteration in virulence, animals were inoculated with strains 237e and 234e, which are single-copy ectopic transformants, by the inhalation and intranasal routes, respectively. No difference in survival curves was observed when these groups were compared with animals inoculated with wild-type isolates (data not shown).
DISCUSSION
Previous attempts to define the pathogenicity determinants of aetiological agents of systemic mycoses, which include Aspergillus spp., Candida spp., and Cryptococcus neoformans, have been based on comparisons of wild-type strains with naturally occurring variants (11) or with mutants generated either by UV light or chemicals (13, 15, 21) and the revertants of some of these mutants (13) . An inherent problem with these approaches is that such strains may carry additional mutations at other loci which could influence the infection process. In an effort to establish the relationship between virulence and the mating type of C. neoformans, Kwon-Chung et al. (12) used a series of backcrosses to construct near-isogenic strains which differed at the matingtype locus. However, as those authors acknowledged, this approach cannot prove a causal relationship between virulence and mating type because of the possibility of close linkage between a virulence-enhancing gene and the matingtype system. In this study, we compared clinical isolates of A. fumigatus with isogenic strains constructed by targeted disruption of a putative pathogenicity gene (24) . This strategy should provide a rigorous test for determining the role of a gene in pathogenesis and has been used recently to refute the hypothesis that cutinase secreted by Fusarium solani var. pisi, a fungal phytopathogen, is required for disease development (23) .
Disruption of the AFAlp gene was performed in two genetic backgrounds, as the relative contribution of virulence determinants may be strain dependent. The Kothary et al. (11) . This difference may have been due to the different fungal and animal strains used in the studies. In contrast to Kothary et al. (11), who found that the majority of conidia of elastase nonproducing isolates failed to germinate in infected mice, most conidia of strain 237d did germinate within the lung (Fig. 4) . The differences they observed between elastase-producing and nonproducing isolates were presumably due to mutations unconnected with the AFAlp gene. We thought that our failure to demonstrate a difference between strains 237 and 237d in terms of mortality or histology with this model might reflect the short interval between inoculation with the fungus and the onset of illness (Fig. 2) . Therefore, we compared strains 234 and 234d by using a murine model of IPA in which the duration of illness is more prolonged. The model employed is a modification of that described by Dixon et al. (7); approximately 50% mortality occurs by day 7, and 70 to 80% mortality occurs by day 12. The animals are inoculated via the respiratory tract and immunosuppressed with corticosteroids. The drawback of this model is that the inoculum is administered as a suspension in saline, which does not replicate the clinical mode of infection. So as not to produce an overwhelming infection, we lowered the fungal inoculum and dose of immunosuppression to the limits that gave reproducible survival curves but were still unable to demonstrate a difference between the two strains. An obvious explanation for the striking difference in survival curves between the two models is apparent from the lung tissue histology. Multiple small foci of infection were found throughout the lung parenchyma following the inhalation of airborne conidia, while in contrast, the pattern of disease was largely bronchocentric after the aspiration of a droplet containing conidia (Fig. 4) . This suggests that while a suspension of conidia inhaled by mice tends to lodge in the major airways, individual airborne conidia, because of their small size (2 to 3 p,m in diameter), reach the distal part of the airways, where they germinate and cause a fulminant fungal pneumonia.
All animals that became ill had evidence of respiratory distress (i.e., labored breathing and subcostal recession). Since this was observed only in mice that were immunosuppressed and inoculated with viable conidia, we conclude that respiratory disease was due to fungal growth and was not the result of other infections, mechanical effects of the inoculum, or allergic reactions to conidia. This conclusion is supported by the histological data obtained from animals in the experimental groups which demonstrated invasive fungal disease.
An important aspect of this work was the demonstration of elastinolysis in lung tissue from animals infected with the AFAlp disruptants. There are several potential causes of the degradation of elastin in lung tissue from animals inoculated with the AFAlp disruptants. First, growth conditions in the microenvironment of an A. fumigatus colony in the lung are unknown, so it is possible that the extremely alkaline or acid proteases reported by Reichard et al. (19) or other as-yetuncharacterized proteases are responsible for the elastinolysis. Second, elastin breakdown may be caused by host enzymes such as PMN leukocyte elastase. Although PMN leukocytes were not always detected at the site of elastinolysis, this does not preclude the possibility that they were responsible for elastin degradation, since they may have migrated or autolyzed after the breakdown of elastin had occurred. Finally, the loss of elastin could be due to nonspecific chemical degradation.
Our results show that AFAlp does not contribute significantly to fungal virulence in these murine models of IPA. However, it is conceivable that AFAlp is one of a number of factors, each with a minor effect, that combine to facilitate disease progression (5) . In addition, this study does not address the question of the role of AFAlp during infection of organs other than the lung (16) . Moreover, the clinical relevance of our findings is uncertain. There are inherent limitations with both animal models: large doses of both fungus and immunosuppression are necessary to induce disease, and animals are immunosuppressed by corticosteroids, while clinically, the major risk factor for the acquisition of IPA is prolonged neutropenia (9) . Accordingly, we intend to assess the pathogenicity of the AFAlp disruptants in neutropenic mice, which may require a lower level of fungal inoculum to produce disease.
